Xeroderma: Difference between revisions
Kiran Singh (talk | contribs) |
|||
| (17 intermediate revisions by 8 users not shown) | |||
| Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
{{CMG}} ; {{ADI}} | {{CMG}} ; {{AOEIC}}{{ADI}} | ||
'''''Synonyms and keywords:''''' xerodermia, dry skin | |||
==Overview== | ==Overview== | ||
'''Xeroderma''' (literally "'''dry skin'''")is a condition involving the [[integumentary system]], which in most cases can safely be treated with emollients and/or moisturizers. Xeroderma occurs most commonly on the lower legs, arms, the sides of the abdomen and thighs. Symptoms most associated with Xeroderma are scaling (the visible peeling of the outer skin layer), itching and cracks in the skin. | '''Xeroderma''' (literally "'''dry skin'''")is a condition involving the [[integumentary system]], which in most cases can safely be treated with emollients and/or moisturizers. Xeroderma occurs most commonly on the lower legs, arms, the sides of the abdomen and thighs. Symptoms most associated with Xeroderma are scaling (the visible peeling of the outer skin layer), itching and cracks in the skin. | ||
| Line 48: | Line 49: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| [[Adapalene]], [[Amcinonide]], [[Atropine]], [[Benoxyl]], [[Benzamycin- topical]], [[Benzoyl Peroxide]], [[Betamethasone]], [[Claravis]], [[Cleocin T topical lotion]], [[Clobetasol]], [[Clofazime]], [[Cordran]], [[Desonide]], [[Dicyclomine]], [[Diflorasone Diacetate]], [[Diphenoxylate]], [[Etretinate]], [[Flucinolone]], [[Fluorouracil]], [[Gefitinib]], [[Hydrocortisone]], [[Hyoscyamine]], [[Isotretinoin]], [[Midodrine]], [[Mometasone]], [[Risperidone]], [[Salicylic acid ]], [[Tazarotene]], [[Thalidomide]], [[Trentinoin]], [[Triamcinolone]] | |bgcolor="Beige"| [[Adapalene]], [[Afatinib]], [[Amcinonide]], [[Atropine]], [[Benoxyl]], [[Benzamycin- topical]], [[Benzoyl Peroxide]], [[Betamethasone]], [[Claravis]], [[Cleocin T topical lotion]], [[Clobetasol]], [[Clofazime]], [[Cordran]], [[Desonide]], [[Dicyclomine]], [[Diflorasone Diacetate]], [[Diphenoxylate]], [[Etretinate]], [[Flucinolone]], [[Fluorouracil]], [[Gefitinib]], [[Halcinonide]], [[Halobetasol]], [[Hydrocortisone]], [[Hyoscyamine]], [[Isotretinoin]], [[Midodrine]], [[Mometasone]], [[Niacin]], [[Panitumumab]], [[Risperidone]], [[Salicylic acid ]], [[Sertaconazole]], [[Siltuximab]], [[Sorafenib]], [[Sunitinib]], [[Tazarotene]], [[Thalidomide]], [[Tiagabine]], [[Trentinoin]], [[Triamcinolone]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| Line 150: | Line 151: | ||
|} | |} | ||
===Alphabetical order=== | ===Causes in Alphabetical order=== | ||
{{col-begin}} {{col-break}} | {{col-begin}} {{col-break}} | ||
*[[1-Pentanethiol ]] | *[[1-Pentanethiol ]] | ||
| Line 291: | Line 292: | ||
*[[Fluorouracil]] | *[[Fluorouracil]] | ||
*[[Fluticasone]] (cream/lotion) | |||
*[[Follicular ichthyosis ]] | *[[Follicular ichthyosis ]] | ||
| Line 377: | Line 380: | ||
*[[Myxedema ]] | *[[Myxedema ]] | ||
*[[Niacin]] | |||
*[[Nicotine addiction ]] | *[[Nicotine addiction ]] | ||
| Line 389: | Line 394: | ||
*[[Panhypopituitarism ]] | *[[Panhypopituitarism ]] | ||
*[[Panitumumab]] | |||
*[[Phenmedipham ]] | *[[Phenmedipham ]] | ||
| Line 421: | Line 428: | ||
*[[Sick building syndrome ]] | *[[Sick building syndrome ]] | ||
*[[Siltuximab]] | |||
*[[Sjogren's syndrome ]] | *[[Sjogren's syndrome ]] | ||
*[[Soap]] | *[[Soap]] | ||
*[[Sorafenib]] | |||
*[[Spinal shock ]] | *[[Spinal shock ]] | ||
*[[Stoll-Alembik-Finck syndrome ]] | *[[Stoll-Alembik-Finck syndrome ]] | ||
*[[Sunitinib]] | |||
*[[Tazarotene]] | *[[Tazarotene]] | ||
| Line 439: | Line 452: | ||
*[[Thalidomide]] | *[[Thalidomide]] | ||
*[[Tiagabine]] | |||
*[[Tranebjaerg-Svejgaard syndrome ]] | *[[Tranebjaerg-Svejgaard syndrome ]] | ||
| Line 471: | Line 486: | ||
* [[ichthyosis]] | * [[ichthyosis]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
Latest revision as of 18:44, 16 June 2015
|
WikiDoc Resources for Xeroderma |
|
Articles |
|---|
|
Most recent articles on Xeroderma |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Xeroderma at Clinical Trials.gov Clinical Trials on Xeroderma at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Xeroderma
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Xeroderma Discussion groups on Xeroderma Directions to Hospitals Treating Xeroderma Risk calculators and risk factors for Xeroderma
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Xeroderma |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-In-Chief:Aditya Govindavarjhulla, M.B.B.S. [2]
Synonyms and keywords: xerodermia, dry skin
Overview
Xeroderma (literally "dry skin")is a condition involving the integumentary system, which in most cases can safely be treated with emollients and/or moisturizers. Xeroderma occurs most commonly on the lower legs, arms, the sides of the abdomen and thighs. Symptoms most associated with Xeroderma are scaling (the visible peeling of the outer skin layer), itching and cracks in the skin.
Causes
Xeroderma is a very common condition. It happens more often in the winter where the cold air outside and the hot air inside creates a low relative humidity. This causes the skin to lose moisture and it may crack and peel. Bathing/showering too frequently, especially if one is using harsh soaps, may also contribute to xeroderma. Xeroderma can also be caused by a deficiency of vitamin A, systemic illness, overexposure to sunlight or some medication.